SCHEMBL5657071

SCHEMBL5657071

COc1ccccc1NC(=O)OCCCN1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.56
MAPT P10636 2/20 0.56
TSHR P16473 1/20 0.56
ALDH1A1 P00352 3/20 0.56
LMNA P02545 1/20 0.56
ADRA1D P25100 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.54
TP53 P04637 1/20 0.53
ALOX15 P16050 1/20 0.52
HTR1A P08908 1/20 0.51
DRD2 P14416 1/20 0.51
HTR2A P28223 1/20 0.51
HRH1 P35367 1/20 0.51
DRD3 P35462 1/20 0.51
TMEM97 Q5BJF2 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656799 0.94 NPSR1 (0.58) NPSR1MAPTTSHRALDH1A1LMNA
SCHEMBL5657864 0.93 L3MBTL1 (0.59) NPSR1MAPTTSHRALDH1A1ADRA1D
SCHEMBL5657621 0.92 NPSR1 (0.59) NPSR1MAPTTSHRALDH1A1LMNA
SCHEMBL5658368 0.92 ADRA1D (0.60) NPSR1MAPTTSHRALDH1A1ADRA1D
SCHEMBL5655987 0.91 NPSR1 (0.69) NPSR1MAPTTSHRLMNAADRA1D
SCHEMBL5656051 0.90 MAPT (0.56) MAPTTP53ALOX15HTR1ADRD2
SCHEMBL5656283 0.89 ADRA1D (0.54) NPSR1MAPTTSHRALDH1A1ADRA1D
SCHEMBL5655966 0.87 NPSR1 (0.69) NPSR1TSHRALDH1A1LMNAADRA1D
SCHEMBL5655841 0.86 ADRA1A (0.71) ALDH1A1ADRA1DADRA1AADRA1BHTR1A
SCHEMBL5655862 0.86 NPSR1 (0.59) NPSR1MAPTTSHRALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C NPSR1 37/4885MAPT 3644/4885TSHR 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.